NCT05615337 (MEDITAGING) is a NA clinical trial of MBSR in Mindfulness, sponsored by University of Luxembourg.

Who is sponsoring NCT05615337?

NCT05615337 is sponsored by University of Luxembourg.

What drugs are being tested in NCT05615337?

Interventions in NCT05615337: MBSR, HPP.

What condition does NCT05615337 study?

NCT05615337 studies Mindfulness, Healthy Aging.

Is NCT05615337 still recruiting?

NCT05615337 is currently completed. Last updated 22 January 2024.

Last reviewed 2024-01-22 · How we verify

NCT05615337: MEDITAGING

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Mindfulness Training: the Effects of a Stress Reduction Program on Older Portuguese-speaking People in Luxembourg

Completed NA Last updated 22 January 2024

What this trial tests

NA trial testing MBSR in Mindfulness in 89 participants. Completed in 31 August 2023.

Timeline

26 April 2022

Primary endpoint
31 August 2023

31 August 2023

Quick facts

Lead sponsor	University of Luxembourg
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	other
Enrollment	89
Start date	26 April 2022
Primary completion	31 August 2023
Estimated completion	31 August 2023
Sites	1 location across Luxembourg

Drugs / interventions tested

MBSR
HPP

Conditions studied

Mindfulness — all drugs for Mindfulness →
Healthy Aging — all drugs for Healthy Aging →

Sponsor

University of Luxembourg

Who can join

55 and older, any sex, with Mindfulness or Healthy Aging. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This project aims to investigate the MBSR feasibility and its effects in old Portuguese-speaking adults living in Luxemburg. This study will be a two-arm randomized-double blinded-controlled study, including 90 healthy older adults. The MBSR will be conducted in groups over a total of eight weeks, incorporating weekly meetings, a retreat of 4 hours, and extra activities to be practiced at home. The active control condition will be a program with different components such as painting, nutrition information, physical activity, cognitive enhancement, risk factors for dementia, and health promotion. Neuropsychological assessments will be conducted at baseline, immediately after and one-month post-intervention. The researchers will also do pre-post salivary cortisol and resting heart rate variability analyses, as surrogate measures to assess stress level.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

The MEDITAGING study: protocol of a two-armed randomized controlled study to compare the effects of the mindfulness-based stress reduction program against a health promotion program in older migrants in Luxembourg.
Teixeira-Santos AC, Gomes L, Pereira DR, Ribeiro F, et al · · 2023 · cited 3× · PMID 38082350 · DOI 10.1186/s12889-023-17387-9
A randomized clinical trial of mindfulness training versus a health promotion program: Impact on cognitive and mental health in older immigrants.
Teixeira-Santos AC, Gomes L, R Pereira D, Ribeiro F, et al · · 2025 · PMID 41210841 · DOI 10.1016/j.ijchp.2025.100642

Verify or expand the search:

Other trials of MBSR

Trials testing the same drug.

NCT07307196 — The Effect of a Mindfulness-Based Stress Reduction Program on Pregnancy Adaptation, Stress, and Fetal Anxiety Levels in · NA · not yet recruiting
NCT06628986 — MBSR and NLP, Postpartum Breastfeeding and Depression · NA · recruiting
NCT06022887 — Time-Restricted Eating and Mindfulness-Based Stress Reduction to Reduce the Risk of Early-Onset Colorectal Cancer · NA · completed
NCT06991309 — Mindfulness-based Stress Reduction Effects on Depression, Anxiety and Internalized Stigma Compared With Treatment-As-Usu · NA · completed
NCT04870957 — The Back Pain Consortium Research Program Study · Phase 4 · completed

Other recruiting trials for Mindfulness

Currently open trials in the same condition.

NCT07351799 — Mindfulness and Meditation Based Lactation Education on Maternal Breastmilk in the Neonatal ICU · NA · recruiting
NCT07171697 — Mindful-Med: the Evaluation of the Mindfulness-based Stress-coping and Burnout Prevention Programme for Medical Interns. · NA · active not recruiting
NCT06642181 — Combined Guanfacine and Mindfulness Meditation as an Adjunct to Buprenorphine Maintenance in Opioid Use Disorder · Phase 1 · recruiting
NCT07195838 — Mindful-Breath for People With COPD · NA · recruiting
NCT07285954 — Mindfulness Walking Intervention to Enhance Resilience (iWalk) · NA · recruiting

Other University of Luxembourg trials

Trials by the same sponsor.

NCT06522750 — Periodic Fasting for Treatment of Long Covid in Adults: a Pilot Study · NA · recruiting
NCT04792177 — Internet-based Emotion Regulation Intervention for Sexual Health · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05615337 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Luxembourg
Last refreshed: 22 January 2024

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05615337.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing